{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:37:56Z","timestamp":1793288276658,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health Disability and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["APP1201062"],"award-info":[{"award-number":["APP1201062"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbi.2025.106206","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:16:54Z","timestamp":1764980214000},"page":"106206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Biomarkers of neuroaxonal and astrocytic pathology in autoimmune encephalitis"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-3287","authenticated-orcid":false,"given":"Robb","family":"Wesselingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Seery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Rushen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirasol","family":"Forcadela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendyl","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke Van","family":"Der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brodtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest G.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kalincik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Macdonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Chao","family":"Foong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"MacIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Malpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bbi.2025.106206_b0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2025.106206_b0010","doi-asserted-by":"crossref","unstructured":"Bastiaansen, A.E.M., van Steenhoven, R.W., de Bruijn, M., et al., 2021. Autoimmune encephalitis resembling dementia syndromes. Neurol. Neuroimmunol. Neuroinflamm., 8(5)doi:10.1212\/NXI.0000000000001039.","DOI":"10.1212\/NXI.0000000000001039"},{"issue":"6","key":"10.1016\/j.bbi.2025.106206_b0015","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.bbi.2025.106206_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103057","article-title":"Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.bbi.2025.106206_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103074","article-title":"Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.bbi.2025.106206_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103118","article-title":"Rare antibody-mediated and seronegative autoimmune encephalitis: an update","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbi.2025.106206_b0035","doi-asserted-by":"crossref","unstructured":"Kazzi, C., Seery, N., Griffith, S., et al., 2025. The relationship between patient-reported quality of life and clinician-rated outcome scores in patients with autoimmune encephalitis: a study of the Australian Autoimmune Encephalitis Consortium. Qual. Life Res., doi:10.1007\/s11136-025-04052-4.","DOI":"10.1007\/s11136-025-04052-4"},{"issue":"6","key":"10.1016\/j.bbi.2025.106206_b0040","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/ane.13503","article-title":"Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis","volume":"144","author":"Chen","year":"2021","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.bbi.2025.106206_b0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.26241","article-title":"Long-term cognitive outcome in anti-N-methyl-D-aspartate receptor encephalitis","volume":"90","author":"Heine","year":"2021","journal-title":"Ann. Neurol."},{"issue":"20","key":"10.1016\/j.bbi.2025.106206_b0050","doi-asserted-by":"crossref","first-page":"e2546","DOI":"10.1212\/WNL.0000000000011937","article-title":"Prospective quantification of CSF biomarkers in antibody-mediated encephalitis","volume":"96","author":"Day","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bbi.2025.106206_b0055","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200360","article-title":"Cognitive deficits in anti-LGI1 encephalitis are linked to immunotherapy-resistant white matter network changes","volume":"12","author":"Krohn","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"9","key":"10.1016\/j.bbi.2025.106206_b0060","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2018-320168","article-title":"Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis","volume":"90","author":"Loane","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106206_b0065","doi-asserted-by":"crossref","unstructured":"Khalil, M., Pirpamer, L., Hofer, E., et al., 2020. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat. Commun., 11(1):812. doi:10.1038\/s41467-020-14612-6.","DOI":"10.1038\/s41467-020-14612-6"},{"issue":"15","key":"10.1016\/j.bbi.2025.106206_b0070","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4155\/bio-2019-0163","article-title":"Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood","volume":"11","author":"Hendricks","year":"2019","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.bbi.2025.106206_b0075","article-title":"Biomarkers of neurobiologic recovery in adults with sport-related concussion","volume":"7","author":"O'Brien","year":"2024","journal-title":"JAMA Netw. Open."},{"issue":"10","key":"10.1016\/j.bbi.2025.106206_b0080","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbi.2025.106206_b0085","doi-asserted-by":"crossref","unstructured":"Siller, N., Kuhle, J., Muthuraman, M., et al., 2018. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis. Mult. Scler., 1352458518765666. doi:10.1177\/1352458518765666.","DOI":"10.1177\/1352458518765666"},{"issue":"8","key":"10.1016\/j.bbi.2025.106206_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1354","article-title":"Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis","volume":"9","author":"Li","year":"2019","journal-title":"Brain Behav."},{"issue":"4","key":"10.1016\/j.bbi.2025.106206_b0095","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/ene.14631","article-title":"Longitudinal measurement of cerebrospinal fluid neurofilament light in anti-N-methyl-D-aspartate receptor encephalitis","volume":"28","author":"Macher","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.bbi.2025.106206_b0100","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00415-019-09306-z","article-title":"Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis","volume":"266","author":"Mariotto","year":"2019","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.bbi.2025.106206_b0105","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ene.12942","article-title":"Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis","volume":"23","author":"Constantinescu","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"21","key":"10.1016\/j.bbi.2025.106206_b0110","doi-asserted-by":"crossref","first-page":"e2204","DOI":"10.1212\/WNL.0000000000207221","article-title":"Predictive value of serum neurofilament light chain levels in anti-NMDA receptor encephalitis","volume":"100","author":"Brenner","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bbi.2025.106206_b0115","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.26067","article-title":"Serum glial Fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker","volume":"89","author":"Aktas","year":"2021","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2025.106206_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70207","article-title":"Glial fibrillary acid protein reflects disease activity in autoimmune encephalitis","volume":"32","author":"Piepgras","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.bbi.2025.106206_b0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.bbi.2025.106206_b0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2025.106206_b0135","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40120-021-00278-9","article-title":"Validation of the clinical assessment scale for autoimmune encephalitis: a multicenter study","volume":"10","author":"Cai","year":"2021","journal-title":"Neurol. Ther."},{"issue":"3","key":"10.1016\/j.bbi.2025.106206_b0140","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.25421","article-title":"Development of the clinical assessment scale in autoimmune encephalitis","volume":"85","author":"Lim","year":"2019","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.bbi.2025.106206_b0145","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.bbi.2025.106206_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bbi.2025.106206_b0155","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1212\/WNL.0000000000200021","article-title":"Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis","volume":"98","author":"Guasp","year":"2022","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbi.2025.106206_b0160","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1007\/s10072-021-05838-3","article-title":"Serum NfL associated with anti-NMDA receptor encephalitis","volume":"43","author":"Ma","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bbi.2025.106206_b0165","doi-asserted-by":"crossref","unstructured":"Eisenhut, K., Faber, J., Engels, D., et al., 2024. Early neuroaxonal damage in neurologic disorders associated with GAD65 antibodies. Neurol. Neuroimmunol. Neuroinflamm., 11(1)doi:10.1212\/NXI.0000000000200176.","DOI":"10.1212\/NXI.0000000000200198"},{"issue":"2","key":"10.1016\/j.bbi.2025.106206_b0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/jnc.15700","article-title":"Serum neurofilament light chain is associated with disturbed limbic-based functional connectivity in patients with anti-NMDAR encephalitis","volume":"164","author":"Chen","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2025.106206_b0175","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fneur.2017.00300","article-title":"Serial sampling of serum protein biomarkers for monitoring human traumatic brain injury dynamics: a systematic review","volume":"8","author":"Thelin","year":"2017","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2025.106206_b0180","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1212\/NXI.0000000000000271","article-title":"Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.bbi.2025.106206_b0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jnen\/60.5.449","article-title":"Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo","volume":"60","author":"Hainfellner","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2025.106206_b0190","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awae035","article-title":"Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles","volume":"147","author":"Sanchez-Juan","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2025.106206_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719432","article-title":"CSF-neurofilament light chain levels in NMDAR and LGI1 encephalitis: a national cohort study","volume":"12","author":"Nissen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.106206_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103000","article-title":"Peripheral monocytes and soluble biomarkers in autoimmune encephalitis","volume":"135","author":"Wesselingh","year":"2023","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.bbi.2025.106206_b0205","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/nn2015","article-title":"Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions","volume":"10","author":"Mildner","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2025.106206_b0210","doi-asserted-by":"crossref","unstructured":"Verkhratsky, A., Butt, A., Li, B., et al., 2023. Astrocytes in human central nervous system diseases: a frontier for new therapies. Signal Transduct. Target Ther. 8(1):396. doi:10.1038\/s41392-023-01628-9.","DOI":"10.1038\/s41392-023-01628-9"},{"key":"10.1016\/j.bbi.2025.106206_b0215","doi-asserted-by":"crossref","unstructured":"Tronel, C., Largeau, B., Santiago Ribeiro, M.J., Guilloteau, D., Dupont, A.C., Arlicot, N., 2017. Molecular targets for PET imaging of activated microglia: the current situation and future expectations. Int. J. Mol. Sci., 18(4)doi:10.3390\/ijms18040802.","DOI":"10.3390\/ijms18040802"},{"issue":"Suppl 201","key":"10.1016\/j.bbi.2025.106206_b0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ane.12845","article-title":"Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis","volume":"136","author":"Zetterberg","year":"2017","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.bbi.2025.106206_b0225","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2025.106206_b0230","doi-asserted-by":"crossref","unstructured":"Aboseif, A., Li, Y., Amin, M., et al., 2024. Clinical determinants of longitudinal disability in LGI-1-IgG autoimmune encephalitis. Neurol. Neuroimmunol. Neuroinflamm., 11(1), doi:10.1212\/NXI.0000000000200178.","DOI":"10.1212\/NXI.0000000000200178"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125004489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125004489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:08:07Z","timestamp":1773875287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125004489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":46,"alternative-id":["S0889159125004489"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106206","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of neuroaxonal and astrocytic pathology in autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106206"}}